Sanofi (SAN-FR)


Sanofi stock research in summary

sanofi.com


Latest Obermatt Ranks

Country France
Industry Pharmaceuticals
Index EURO STOXX 50, CAC 40, CAC All, SBF 120
Size class XX-Large

October 27, 2017. Top 10 stocks updated on Top 10 schedule or at least quarterly. ()







 

Research History: Sanofi

STOCK RESEARCH SUMMARY 2014 2015 2016 2017
STOCK VALUE RANKS
88
92
79
85
STOCK GROWTH RANKS
29
50
6
61
STOCK SAFETY RANKS
81
91
92
75
COMBINED STOCK RANKS
91
95
82
92

Last update of Combined Rank: 27-Oct-2017

Historic Sanofi stock analysis based on the Obermatt Method. The higher the rank, the better is Sanofi in the corresponding investment strategy.


Value Metrics in Detail

VALUE METRICS 2014 2015 2016 2017
PRICE VS. REVENUES (P/S)
43
62
41
44
PRICE VS. PROFITS (P/E)
75
81
57
94
PRICE VS. CAPITAL (Market-to-Book)
68
69
68
66
DIVIDEND YIELD
93
86
96
91
CONSOLIDATED RANK: VALUE
88
92
79
85

Last update of Value Rank: 27-Oct-2017

Sanofi stock analysis in respect to important value ratios. The higher the rank, the lower the value ratio; except for dividend yield where the rank is higher the higher the yield.


Growth Metrics in Detail

GROWTH METRICS 2014 2015 2016 2017
REVENUE GROWTH
30
62
1
5
PROFIT GROWTH
48
62
18
77
STOCK RETURNS
21
36
16
50
CONSOLIDATED RANK: GROWTH
29
50
6
61

Financial reporting date of Growth Rank: 30-Jun-2017

Sanofi stock analysis in respect to important growth metrics. The higher the rank, the higher the growth and returns.


Safety Metrics in Detail

SAFETY METRICS 2014 2015 2016 2017
LEVERAGE
46
54
65
46
REFINANCING
41
LIQUIDITY
80
85
78
88
CONSOLIDATED RANK: SAFETY
81
91
92
75

Financial reporting date of Safety Rank: 20-Oct-2017

Sanofi stock analysis in respect ot important safety metrics. The higher the rank, the lower the leverage and the more cash is available to service the debt.

Stock analysis by the purely finance fact-based Obermatt Method for the investment strategies Value, Growth and Safety for Sanofi (SAN-FR) from October 27, 2017.